Article
Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus
30 Nov 2020
Abstract excerpt
Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID-19) are urgently required. We studied an already-approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related virus. RNA-sequencing results showed the virus perturbed the expression of multiple genes including those associated with cellular stress...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
